GEN Exclusives

More »

GEN News Highlights

Back to Item »

BGI Chooses Agilent’s Platforms to Optimize Next-Generation Sequencing Work

BGI will use the SureSelect Target Enrichment System, the Bravo Automated Liquid Handling Platform, and the 2100 Bioanalyzer.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?